Comparison of Thrombotic Events and Mortality in Patients with Community-Acquired Pneumonia and COVID-19: A Multicenter Observational Study.


Journal

Thrombosis and haemostasis
ISSN: 2567-689X
Titre abrégé: Thromb Haemost
Pays: Germany
ID NLM: 7608063

Informations de publication

Date de publication:
02 2022
Historique:
aheadofprint: 10 11 2021
pubmed: 11 11 2021
medline: 22 2 2022
entrez: 10 11 2021
Statut: ppublish

Résumé

It is still unclear if patients with community-acquired pneumonia (CAP) and coronavirus disease 2019 (COVID-19) have different rate, typology, and impact of thrombosis on survival. In this multicenter observational cohort study, 1,138 patients, hospitalized for CAP ( During the in-hospital stay, 11.4% of CAP and 15.5% of COVID-19 patients experienced thrombotic events ( Compared with CAP, COVID-19 is characterized by a higher burden of thrombotic events, different thrombosis typology and higher risk of thrombosis-related in-hospital mortality.

Sections du résumé

BACKGROUND
It is still unclear if patients with community-acquired pneumonia (CAP) and coronavirus disease 2019 (COVID-19) have different rate, typology, and impact of thrombosis on survival.
METHODS
In this multicenter observational cohort study, 1,138 patients, hospitalized for CAP (
RESULTS
During the in-hospital stay, 11.4% of CAP and 15.5% of COVID-19 patients experienced thrombotic events (
CONCLUSION
Compared with CAP, COVID-19 is characterized by a higher burden of thrombotic events, different thrombosis typology and higher risk of thrombosis-related in-hospital mortality.

Identifiants

pubmed: 34758488
doi: 10.1055/a-1692-9939
doi:

Types de publication

Clinical Trial Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

257-266

Subventions

Organisme : RM118164366B89BD
ID : Sapienza University of Rome

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Roberto Cangemi (R)

Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.

Camilla Calvieri (C)

Department of Clinical Internal, I Clinica Medica, Anaesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.

Marco Falcone (M)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Francesco Cipollone (F)

Department of Medicine and Aging, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy.

Giancarlo Ceccarelli (G)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Pasquale Pignatelli (P)

Department of Clinical Internal, I Clinica Medica, Anaesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Mediterranea Cardiocentro, Naples, Italy.

Damiano D'Ardes (D)

Department of Medicine and Aging, "G. D'Annunzio" University of Chieti-Pescara, Chieti, Italy.

Matteo Pirro (M)

Unit of Internal Medicine, Department of Medicine, University of Perugia, Perugia, Italy.

Francesco Alessandri (F)

Department of General Surgery Paride Stefanini, Sapienza University of Rome, Rome, Italy.

Miriam Lichtner (M)

Infectious Diseases Unit, Santa Maria Goretti Hospital, Sapienza University of Rome, Latina, Italy.

Gabriella D'Ettorre (G)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Alessandra Oliva (A)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Raissa Aronica (R)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Monica Rocco (M)

Department of Clinical and Surgical Translational Medicine, Sant' Andrea Hospital, Sapienza University of Rome, Rome, Italy.

Mario Venditti (M)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Giulio Francesco Romiti (GF)

Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.

Giusy Tiseo (G)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Gloria Taliani (G)

Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.

Francesco Menichetti (F)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Francesco Pugliese (F)

Department of General Surgery Paride Stefanini, Sapienza University of Rome, Rome, Italy.

Claudio Maria Mastroianni (CM)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

Francesco Violi (F)

Department of Clinical Internal, I Clinica Medica, Anaesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Mediterranea Cardiocentro, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH